Ventyx Biosciences, Inc. (VTYX)
Mar 4, 2026 - VTYX was delisted (reason: acquired by LLY)
14.00
+0.02 (0.14%)
Inactive · Last trade price
on Mar 3, 2026
Ventyx Biosciences Analyst Ratings
Total Analysts
7
Consensus Rating
Hold
Price Target
$13.50
Upside
-3.57%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 8, 2026 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $14 | Buy → Hold | Downgrades | $14 | n/a | Jan 8, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | n/a | Jan 8, 2026 |
| UBS | UBS | Strong Buy → Hold Downgrades $20 → $14 | Strong Buy → Hold | Downgrades | $20 → $14 | n/a | Jan 8, 2026 |
| LifeSci Capital | LifeSci Capital | Buy → Hold Downgrades $14 | Buy → Hold | Downgrades | $14 | n/a | Jan 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $16 → $14 | Strong Buy → Hold | Downgrades | $16 → $14 | n/a | Jan 8, 2026 |
| UBS | UBS | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +42.86% | Jan 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +14.29% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | n/a | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $18 | Hold → Strong Buy | Upgrades | $18 | +28.57% | Nov 5, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $14 | Buy | Maintains | $9 → $14 | n/a | Oct 27, 2025 |
| Clear Street | Clear Street | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | -21.43% | Oct 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | -57.14% | Nov 11, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $10 → $9 | Buy | Reiterates | $10 → $9 | -35.71% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | -57.14% | Oct 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.